|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/495 | (2006.01) |
| C07K 14/71 | (2006.01) |
| (11) | Number of the document | 2370463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09761055.4 |
| Date of filing the European patent application | 2009-11-24 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation | 2016-12-12 |
| (86) | Number | PCT/US2009/006252 |
| Date | 2009-11-24 |
| (87) | Number | WO 2010/062383 |
| Date | 2010-06-03 |
| (30) | Number | Date | Country code |
| 200250 P | 2008-11-26 | US | |
| 259060 P | 2009-11-06 | US |
| (72) |
SUN, Jeonghoon, US
TAM, Lei-Ting Tony, US
MICHAELS, Mark Leo, US
BOONE, Thomas C., US
DESHPANDE, Rohini, US
LI, Yue-Sheng, US
HAN, Hq, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Stabilizuotas aktivino IIB receptoriaus variantas |
| A STABILIZED VARIANT OF ACTIVIN IIB RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2017-02-27 | 8 | 277.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-11-24 |